Seeking Accountability From CIHR for its Failed Decision-Making

Canadian health ethics researchers request action on problems at CIHR in letter to members of the Canadian Parliament and Senate.

 _____________________________________________________________________

memorialFaculty of Medicine
Division of Community Health and Humanities
The Health Sciences Centre
St. John’s, NL Canada A1B 3V6
Tel: 709 777 6213/6652 Fax: 709 777 7382
www.med.mun.ca

 

April 10, 2014

Ms. Rona Ambrose, Minister of Health
Mr. James Moore, Minister of Industry
Mr. Greg Rickford, Minister of State (Science and Technology)
Mr. Ben Lobb, Chair, House of Commons Standing Committee on Health
Dr. Hedy Fry, Vice-Chair, Standing Committee on Health
Ms. Libby Davies, Vice-Chair, Standing Committee on Health
Mr. David Sweet, Chair, House of Commons Standing Committee on Industry, Science and Technology
Mr. Chris Charlton, Vice-Chair, House of Commons Standing Committee on Industry, Science and Technology
Ms. Judy Sgro, Vice-Chair, House of Commons Standing Committee on Industry, Science and Technology
Mr. Kennedy Stewart, New Democratic Party Critic, Science and Technology
Mr. Ted Hsu, Liberal Party Critic, Science and Technology
Mr. Jack Harris, MP St. John’s East
Dr. Kelvin Ogilvie, Chair, Senate Standing Committee on Social Affairs, Science, Technology
Mr. Art Eggleton, Deputy Chair, Senate Standing Committee on Social Affairs, Science, Technology

Dear Honourable Members of Parliament and Senators,

We are writing to draw your attention to a significant problem with ethics at the Canadian Institutes of Health Research (CIHR).

A Task Force on Ethics Reform at CIHR was formed in November 2012. The mandate of the Task Force was “to evaluate whether CIHR currently meets its ethics mandate and whether the current organizational structure is optimal to do so.”  The Task Force issued a final report in Spring 2013 and therein made a series of findings and recommendations.

The findings included the following:

…CIHR has a clear legal obligation to have a strong and substantive ethics programme as an essential part of its broader mandate to improve the health of all Canadians. [emphasis added]

We emphasize again that CIHR’s ethics mandate is derived directly from the CIHR Act. As a result, CIHR is obligated legally to ensure that ethics has a central place within the organization. This is not optional; it is legally required. No one at CIHR has the authority to denigrate the value or place of ethics because the central place of ethics is prescribed by law. A refreshed vision for ethics must reclaim and re-establish the centrality of CIHR’s ethics mandate by recommitting to its obligations outlined by statute through strong leadership. [emphasis added]

In sum, the Task Force’s findings make it clear that CIHR has not been meeting its statutory mandate.

The recommendations included the following:

We have one key recommendation from which all others flow: provide ethics leadership to CIHR. Fulfilling its legislated mandate in ethics requires both a vision for ethics and responsible ethics leadership at every level of the CIHR corporate structure (including GC and the executive leadership) across all Institutes and programs. … “A first (and this is only the first) step is to create a position of Vice President of Ethics (VP Ethics), or a position of equivalent stature, and then hiring a strong individual to fill that role.

In order to properly reflect the prominence of ethics within the CIHR mandate, this person must have earned a standing within the research ethics community that is at least analogous to that of the Institutes’ Scientific Directors. He or she must have the knowledge, skills and experience to elevate the status of ethics to a position within the organization that more fairly reflects the prominence of ethics in the CIHR mandate, and to develop and execute innovative, world-class programming in research ethics and related research policy. The person in this position should be recognized nationally and internationally as a leading scholar and researcher in ethics familiar with interdisciplinary approaches to research in and application of ethics.

The CIHR Governing Council has elected not to create the position of Vice President of Ethics.  Governing Council has instead decided to appoint Dr. Jane Aubin (a bone biologist and geneticist and Chief Scientific Officer/Vice-President, Research and Knowledge Translation at CIHR) as the “Ethics Champion,” and Dr. Paul Garfinkel  (professor of psychiatry at the University of Toronto and member of CIHR Governing Council) as the Chair of the Standing Committee on Ethics.  Neither of these individuals has ethics expertise and neither is “recognized nationally and internationally as a leading scholar and researcher in ethics.”

The members of the Task Force on Ethics Reform have expressed their disappointment with the CIHR Management Response: “To speak plainly, we do not see the plan proposed as a significant advance beyond the current situation at CIHR – one in which ethics has been pushed to [the] periphery.” A similar concern is evident in the letter from the Vice-Chair of the CIHR Standing Committee on Ethics: “I must express my disappointment that the primary recommendation of the Ethics Task Force Report [expert leadership devoted to ethics] has been abandoned.” As well, the CIHR Institute Advisory Board Ethics Designates have registered their concern that the CIHR response to the Task Force report “sends a contradictory message that leading ethics within CIHR does not require relevant knowledge, expertise or experience in spite of CIHR’s commitment to evidence-based medicine.”

The full details and supporting documentation are all available online at
http://noveltechethics.ca/what-we-do/governance-of-research#Ethics.

Given the failure of CIHR Governing Council to respond appropriately to the Task Force on Ethics Reform findings and recommendations and the concerns expressed by its own internal ethics advisors, it is imperative that Parliament make it clear to the CIHR President and Governing Council that the mandate set out for CIHR in the Canadian Institutes of Health Research Act must be met.

We are therefore writing to you who are leaders in Parliament in the areas of health, industry, and science and technology to request that you take whatever steps are necessary to ensure that the President and Chair of the Governing Council of CIHR (Alain Beaudet) is called to appear before the relevant House/Senate Committees to respond to the deficiencies with respect to ethics at CIHR.   You then will be able to ensure that the legislated ethics mandate will indeed be met.  The public interest and trust in health research in Canada depends upon this.

Sincerely,

Chris Kaposy, Memorial University
Dave Snow, Dalhousie University
Fern Brunger, Memorial University
Matthew Herder, Dalhousie University
Jonathan Kimmelman, McGill University
Angus Dawson, University of Birmingham, UK
Sheila Wildeman, Dalhousie University
Samantha J Brennan, Western University
Françoise Baylis, Dalhousie University
Jocelyn Downie, Dalhousie University
Trudo Lemmens, University of Toronto
Carolyn McLeod, University of Toronto, Western University
Gillian K. D. Crozier, Laurentian University
Ross Upshur, University of Toronto
Walter Glannon, University of Calgary
Nuala Kenny, Dalhousie University
Wayne Sumner, University of Toronto
Jeff Nisker, Western University
Kirstin Borgerson, Dalhousie University
Abby Lippman, McGill University
Jennifer Flynn, Memorial University
Susan Sherwin, Dalhousie University
Janet L. Storch, University of Victoria
Jennifer Chandler, University of Ottawa
Paul Byrne, University of Alberta
Beatrice Godard, Université de Montreal
Constance MacIntosh, Dalhousie University
Angela Cameron, University of Ottawa
Glenn G. Griener, University of Alberta
Cheryl Cline, Queen’s University
Ian Mitchell, University of Calgary
Sue McRae, University of Toronto
Elaine Gibson, Dalhousie University
Jeremy Snyder, Simon Fraser University
Meredith Schwartz, Ryerson University
Kieran O’Doherty, University of Guelph
Patricia Rodney, University of British Colombia
Solomon Benatar, University of Toronto
Pat Murphy, Health Care Ethics Service, St. Boniface General Hospital
Michelle Giroux, University of Ottawa
Alana Klein, McGill University
Barbara Secker, University of Toronto
Roxanne Mykitiuk, York University
Vardit Ravitsky, Université de Montreal
Juliet Guichon, University of Calgary
George C. Webster, St. Boniface General Hospital, Health Care Ethics Service
Lisa Schwartz, McMaster University
Erin Nelson, University of Alberta
Udo Schuklenk, Queens University
Ian Kerr, University of Ottawa

____________________

Attached:

Task Force on Ethics Reform FINAL REPORT
Task Force on Ethics Reform [selected excerpts]
Letters from: Task Force on Ethics Reform, VP Standing Committee on EthicsInstitute Advisory Board Ethics Designates
Article in Research Money

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s